ZNHIT6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.643600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.571400E-01
Normal-vs-Stage2
6.064400E-01
Normal-vs-Stage3
2.460400E-01
Normal-vs-Stage4
3.860400E-01
Stage1-vs-Stage2
8.888800E-01
Stage1-vs-Stage3
3.697000E-01
Stage1-vs-Stage4
8.362300E-02
Stage2-vs-Stage3
3.350400E-01
Stage2-vs-Stage4
5.169900E-02
Stage3-vs-Stage4
7.386400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.541000E-01
Normal-vs-AfricanAmerican
9.580800E-01
Normal-vs-Asian
1.909360E-01
Caucasian-vs-AfricanAmerican
3.533800E-01
Caucasian-vs-Asian
2.441600E-01
AfricanAmerican-vs-Asian
1.778220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.212000E-01
Normal-vs-Female
6.354000E-01
Male-vs-Female
4.697800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.079200E-01
Normal-vs-Age(41-60Yrs)
9.621600E-01
Normal-vs-Age(61-80Yrs)
4.060400E-01
Normal-vs-Age(81-100Yrs)
1.966380E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.193800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.043600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.566800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.981900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.095500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.468800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.104800E-01
Normal-vs-Daily Drinker
3.491000E-01
Normal-vs-Weekly Drinker
3.381000E-01
Normal-vs-Occasional Drinker
6.695000E-01
Normal-vs-Social Drinker
8.315000E-01
Non Drinker-vs-Daily Drinker
8.424800E-01
Non Drinker-vs-Weekly Drinker
8.752600E-01
Non Drinker-vs-Occasional Drinker
1.141210E-01
Non Drinker-vs-Social Drinker
1.330600E-01
Daily Drinker-vs-Weekly Drinker
9.846600E-01
Daily Drinker-vs-Occasional Drinker
2.475600E-01
Daily Drinker-vs-Social Drinker
2.586400E-01
Weekly Drinker-vs-Occasional Drinker
2.740800E-01
Weekly Drinker-vs-Social Drinker
3.045400E-01
Occasional Drinker-vs-Social Drinker
8.501200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.471200E-01
Normal-vs-Grade 2
7.900800E-01
Normal-vs-Grade 3
7.732400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.621500E-03
Grade 1-vs-Grade 3
1.468000E-02
Grade 1-vs-Grade 4
9.471200E-01
Grade 2-vs-Grade 3
7.412000E-01
Grade 2-vs-Grade 4
7.900800E-01
Grade 3-vs-Grade 4
7.732400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.384600E-01
Normal-vs-NonDiabetic
4.197000E-01
Diabetic-vs-NonDiabetic
8.550000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.432400E-01
Normal-vs-NoPancreatitis
4.665400E-01
Pancreatitis-vs-NoPancreatitis
7.491000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.437600E-01
Normal-vs-N1
6.145000E-01
N0-vs-N1
5.637600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.545400E-01
Normal-vs-TP53-NonMutant
6.096200E-01
TP53-Mutant-vs-TP53-NonMutant
1.097980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
